On Friday, Portola Pharmaceuticals (NASDAQ: PTLA) filed a $115 million initial public offering with the SEC. The company plans ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE